As an initial step to understand the role of iRhom1 in regulating drug sensitivity, we analyzed the data in the Cancer Therapeutics Response Portal (CTRP)18, a database of large-scale cancer cell line drug screening that correlates genetic biomarkers with the response to over 300 anti-cancer agents. The gene discussed is RHBDF1; the disease is cancer.